NovaBay Pharmaceuticals (NBY) Short Interest Ratio & Short Volume $0.63 -0.01 (-2.10%) Closing price 02/21/2025 04:10 PM EasternExtended Trading$0.65 +0.02 (+3.81%) As of 02/21/2025 07:44 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Short Interest Stock AnalysisChartEarningsFinancialsHeadlinesInsider TradesSEC FilingsShort Interest NovaBay Pharmaceuticals Short Interest DataNovaBay Pharmaceuticals (NBY) has a short interest of 81,600 shares. This marks a -77.93% decrease in short interest from the previous month. The short interest ratio (days to cover) is 0.3, indicating that it would take 0.3 days of the average trading volume of 327,966 shares to cover all short positions.Current Short Interest81,600 sharesPrevious Short Interest369,700 sharesChange Vs. Previous Month-77.93%Dollar Volume Sold Short$0.00Short Interest Ratio0.3 Days to CoverLast Record DateJanuary 31, 2025Outstanding Shares4,210,000 sharesPercentage of Shares Shorted1.94%Today's Trading Volume81,152 sharesAverage Trading Volume327,966 sharesToday's Volume Vs. Average25% Short Selling NovaBay Pharmaceuticals? Sign up to receive the latest short interest report for NovaBay Pharmaceuticals and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort Interest ChartDays to Cover ChartShort Percent of Float ChartNBY Short Interest Over TimeNBY Days to Cover Over TimeNBY Percentage of Float Shorted Over Time NovaBay Pharmaceuticals Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 1/31/202581,600 shares $0.00 -77.9%N/A0.3 $0.00 1/15/2025369,700 shares $0.00 +487.8%N/A0.7 $0.00 12/31/202462,900 shares $0.00 +63.8%N/A0.1 $0.00 12/15/202438,400 shares $0.00 -47.5%N/A0.1 $0.00 11/30/202473,200 shares $0.00 -60.9%N/A0 $0.00 11/15/2024187,000 shares $0.00 -75.5%N/A0.1 $0.00 10/31/2024764,300 shares $0.00 +4,169.8%N/A0.3 $0.00 10/15/202417,900 shares $0.00 -96.0%N/A0 $0.00 9/30/2024451,700 shares $0.00 +256.5%N/A0.2 $0.00 9/15/2024126,700 shares $0.00 -6.8%N/A0 $0.00 Get the Latest News and Ratings for NBY and Related StocksEnter your email address below to receive the latest news and analysts' ratings for NovaBay Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. 8/31/2024135,900 shares $0.00 -29.3%N/A0.5 $0.00 8/15/2024192,200 shares $0.00 +495.1%N/A0.6 $0.00 7/31/202432,300 shares $0.00 -66.0%N/A0.1 $0.00 7/15/202494,900 shares $0.00 +27.0%N/A0.3 $0.00 6/30/202474,700 shares $0.00 +54.0%N/A0.2 $0.00 6/15/202448,500 shares $0.00 -92.5%N/A0.2 $0.00 5/31/2024647,600 shares $0.00 +2,023.3%84.7%2.3 $0.00 5/15/202430,500 shares $0.00 -77.7%0.1%0 $0.00 4/30/2024137,000 shares $0.00 -34.2%0.4%0.1 $0.00 4/15/2024208,100 shares $0.00 -71.1%0.6%0.1 $0.00 3/31/2024718,800 shares $0.00 +519.1%2.5%0.2 $0.00 3/15/2024116,100 shares $0.00 -57.3%0.4%0 $0.00 2/29/2024271,700 shares $0.00 -10.2%4.3%0.1 $0.00 2/15/2024302,400 shares $0.00 -47.6%4.8%0.1 $0.00 1/31/2024576,600 shares $0.00 +33.4%9.1%0.2 $0.00 1/15/2024432,400 shares $0.00 +1,226.4%6.8%0.6 $0.00 12/31/202332,600 shares $0.00 +136.2%0.5%0.1 $0.00 12/15/202313,800 shares $0.00 -58.7%0.2%0.1 $0.00 11/30/202333,400 shares $0.00 -40.8%0.5%0 $0.00 11/15/202356,400 shares $0.00 -39.1%0.9%0.1 $0.00 10/31/202392,600 shares $0.00 +21.5%2.3%0.1 $0.00 10/15/202376,200 shares $0.00 No Change1.9%0.1 $0.00 9/30/202376,200 shares $0.00 -73.0%1.9%0.1 $0.00 9/15/2023281,700 shares $0.00 +54.6%6.9%0.2 $0.00 8/31/2023182,200 shares $0.00 +0.9%4.5%0.2 $0.00 8/15/2023180,600 shares $0.00 +10.9%4.5%0.8 $0.00 7/31/2023162,900 shares $114,078.87 -43.4%4.0%0.3 $0.70 7/15/2023287,600 shares $0.00 -6.0%7.1%0.5 $0.00 6/30/2023305,900 shares $230,097.98 +9.8%7.6%0.6 $0.75 6/15/2023278,600 shares $186,076.94 +22.1%7.0%0.5 $0.67Do this Before Elon’s Reveal on March 17th (Ad)Elon’s newest tech could pay you an extra $30,000 a year — while you sleep. It’s smaller than a quarter but designed to power a $9 trillion AI revolution. And I’ve identified a little-known supplier Elon is depending on to make it all happen.I urge you to watch this video now. 5/31/2023228,100 shares $148,242.19 +53.6%9.1%0.5 $0.65 5/15/2023148,500 shares $0.00 -6.1%6.3%0.4 $0.00 4/30/2023158,100 shares $0.00 +81.7%8.3%1.7 $0.00 4/15/202387,000 shares $156,600.00 -2.9%5.0%1 $1.80 3/31/202389,600 shares $0.00 +3.9%5.2%3.3 $0.00 3/15/202386,200 shares $0.00 -10.2%5.0%1.9 $0.00 2/28/202396,000 shares $0.00 -3.1%5.5%1.9 $0.00 2/15/202399,100 shares $0.00 +0.1%5.7%1.7 $0.00 1/31/202399,000 shares $245,173.50 +3.0%5.7%1.4 $2.48 1/15/202396,100 shares $0.00 +115.5%5.6%1.4 $0.00 12/30/202244,600 shares $86,970.00 +8.0%2.8%0.6 $1.95 12/15/202241,300 shares $0.00 +7.8%N/A0.7 $0.00 11/30/202238,300 shares $0.00 +2.7%N/A0.6 $0.00 11/15/202237,300 shares $0.00 -96.6%N/A0.7 $0.00 10/31/20221,100,000 shares $0.00 -19.7%N/A0.8 $0.00 10/15/20221,370,000 shares $0.00 +88.0%N/A1 $0.00 9/30/2022728,800 shares $0.00 -17.4%N/A0.7 $0.00 9/15/2022881,900 shares $0.00 -48.1%N/A1.1 $0.00 8/31/20221,700,000 shares $0.00 -5.6%N/A2.8 $0.00 8/15/20221,800,000 shares $0.00 +30.4%N/A2.5 $0.00 7/31/20221,380,000 shares $0.00 +11.3%26.8%1.8 $0.00 7/15/20221,240,000 shares $0.00 -1.6%24.1%2 $0.00 6/30/20221,260,000 shares $0.00 -9.4%24.5%2 $0.00 6/15/20221,390,000 shares $0.00 +7.8%27.0%2.3 $0.00 5/31/20221,290,000 shares $0.00 +41.6%N/A2.2 $0.00 5/15/2022910,800 shares $0.00 -1.5%N/A2.1 $0.00 4/30/2022924,900 shares $0.00 +11.6%2.2%2.3 $0.00 4/15/2022828,800 shares $0.00 -9.8%2.0%2.1 $0.00 3/31/2022918,800 shares $272,240.44 -10.8%2.2%2.1 $0.30 3/15/20221,030,000 shares $0.00 +15.7%2.6%1.7 $0.00 2/28/2022890,200 shares $0.00 -7.1%2.3%1.3 $0.00 2/15/2022957,800 shares $0.00 -14.5%2.5%1.2 $0.00 1/31/20221,120,000 shares $0.00 -22.2%3.2%1.3 $0.00 1/15/20221,440,000 shares $0.00 -13.3%4.1%1.5 $0.00 12/31/20211,660,000 shares $0.00 -20.2%4.7%1.8 $0.00 12/15/20212,080,000 shares $0.00 -10.3%5.9%2.1 $0.00 11/30/20212,320,000 shares $0.00 +19.6%6.5%2.3 $0.00 11/15/20211,940,000 shares $0.00 +22.0%5.4%2.3 $0.00 10/29/20211,590,000 shares $842,700.00 -25.7%N/A1.8 $0.53 10/15/20212,140,000 shares $0.00 +5.9%6.0%1.3 $0.00 9/30/20212,020,000 shares $0.00 +4.7%5.7%1 $0.00 9/15/20211,930,000 shares $0.00 -6.8%5.4%1.1 $0.00 8/31/20212,070,000 shares $0.00 -5.1%5.9%1 $0.00 8/13/20212,180,000 shares $0.00 +29.8%6.2%1 $0.00 7/30/20211,680,000 shares $0.00 +44.8%5.2%0.8 $0.00 7/15/20211,160,000 shares $0.00 +8.4%3.6%1 $0.00 6/30/20211,070,000 shares $0.00 +29.3%3.3%1.3 $0.00 6/15/2021827,400 shares $0.00 -20.4%2.5%0.8 $0.00 5/28/20211,040,000 shares $0.00 +2.0%3.2%0.9 $0.00 5/14/20211,020,000 shares $0.00 -8.9%N/A0.6 $0.00Texas approves new currency (Ad)Rural Texas Town Ramps Up Global Currency War A small town has joined a radical $1.9 trillion attack on the global banking system... backed up by Elon Musk and the White House.Read about it here. 4/30/20211,120,000 shares $0.00 -9.7%N/A0.3 $0.00 4/15/20211,240,000 shares $954,800.00 +6.9%N/A0.3 $0.77 3/31/20211,160,000 shares $928,000.00 +13.7%N/A0.2 $0.80 3/15/20211,020,000 shares $856,800.00 +53.1%N/A0.2 $0.84 2/26/2021666,400 shares $673,064.00 -22.6%N/A0.1 $1.01 2/12/2021861,400 shares $783,874.00 -22.4%N/A0.2 $0.91 1/29/20211,110,000 shares $1.38 million +6.7%N/A0.4 $1.24 1/15/20211,040,000 shares $1.25 million +2.0%N/A0.4 $1.20 12/31/20201,020,000 shares $740,418.00 -22.7%N/A0.6 $0.73 12/15/20201,320,000 shares $918,588.00 +10.0%N/A0.9 $0.70 11/30/20201,200,000 shares $762,000.00 +26.3%N/A0.9 $0.64 11/15/2020950,500 shares $577,333.70 -1.8%N/A0.8 $0.61 10/30/2020968,000 shares $599,869.60 +18.0%N/A0.4 $0.62 10/15/2020820,100 shares $627,376.50 +106.3%N/A0.3 $0.77 9/30/2020397,500 shares $290,175.00 -22.8%N/A0.1 $0.73 9/15/2020515,100 shares $370,872.00 +0.8%N/A0.1 $0.72 8/31/2020511,200 shares $388,512.00 -6.4%N/A0.1 $0.76 8/14/2020546,200 shares $475,194.00 +12.0%N/A0.1 $0.87 7/31/2020487,900 shares $473,263.00 -60.7%N/A0.1 $0.97 7/15/20201,240,000 shares $1.53 million +267.4%N/A0.2 $1.23 6/30/2020337,500 shares $401,625.00 +35.5%1.7%0.1 $1.19 6/15/2020249,000 shares $288,840.00 +49.4%1.3%0.1 $1.16 5/29/2020166,700 shares $208,375.00 -55.8%1.0%0 $1.25 5/15/2020376,700 shares $320,195.00 +16.2%2.3%0.1 $0.85 4/30/2020324,300 shares $288,627.00 -20.5%1.9%0.1 $0.89 4/15/2020407,800 shares $411,878.00 +14.2%2.5%0.1 $1.01 3/31/2020357,000 shares $321,300.00 +150.0%2.2%0.2 $0.90 3/13/2020142,800 shares $107,100.00 +44.4%0.9%0.6 $0.75 2/28/202098,900 shares $89,999.00 -34.7%0.6%0.4 $0.91 NBY Short Interest - Frequently Asked Questions What is NovaBay Pharmaceuticals' current short interest? Short interest is the volume of NovaBay Pharmaceuticals shares that have been sold short but have not yet been closed out or covered. As of January 31st, investors have sold 81,600 shares of NBY short. Learn More on NovaBay Pharmaceuticals' current short interest. Is NovaBay Pharmaceuticals' short interest increasing or decreasing? NovaBay Pharmaceuticals saw a decrease in short interest during the month of January. As of January 31st, there was short interest totaling 81,600 shares, a decrease of 77.9% from the previous total of 369,700 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. How does NovaBay Pharmaceuticals' short interest compare to its competitors? Here is how the short interest of companies in the industry of "pharmaceutical products" compare to NovaBay Pharmaceuticals: Inhibitor Therapeutics, Inc. (0.00%), BetterLife Pharma Inc. (0.02%), BioCardia, Inc. (1.41%), PharmaCyte Biotech, Inc. (0.50%), Kiora Pharmaceuticals, Inc. (0.68%), Integrated BioPharma, Inc. (0.01%), Talphera, Inc. (0.54%), BriaCell Therapeutics Corp. (2.78%), Cyclerion Therapeutics, Inc. (7.07%), Turnstone Biologics Corp. (3.54%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: AppLovin Co. ($5.21 billion), Charter Communications, Inc. ($4.07 billion), Reddit, Inc. ($3.33 billion), The Kroger Co. ($2.67 billion), Cencora, Inc. ($2.29 billion), Hims & Hers Health, Inc. ($2.17 billion), SoFi Technologies, Inc. ($1.99 billion), Live Nation Entertainment, Inc. ($1.87 billion), Rivian Automotive, Inc. ($1.76 billion), and Moderna, Inc. ($1.60 billion). View all of the most shorted stocks. What does it mean to sell short NovaBay Pharmaceuticals stock? Short selling NBY is an investing strategy that aims to generate trading profit from NovaBay Pharmaceuticals as its price is falling. NBY shares are trading down $0.01 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against NovaBay Pharmaceuticals? A short squeeze for NovaBay Pharmaceuticals occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of NBY, which in turn drives the price of the stock up even further. How often is NovaBay Pharmaceuticals' short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including NBY, twice per month. The most recent reporting period available is January, 31 2025. More Short Interest Resources from MarketBeat Related Companies INTI Short Interest Data BETRF Short Interest Data BCDA Short Interest Data PMCB Short Interest Data KPRX Short Interest Data INBP Short Interest Data TLPH Short Interest Data BCTX Short Interest Data CYCN Short Interest Data TSBX Short Interest Data Short Interest Tools Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NYSEAMERICAN:NBY) was last updated on 2/23/2025 by MarketBeat.com Staff From Our PartnersCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredHas Trump finally met his match?Dylan Jovine predicted the 2008 crash over a year before it happened. Folks who listened to him had the chance...Behind the Markets | SponsoredElon “obliterates” Bill Gates?All 10 of the world's biggest money managers follow my work, and the Pentagon, the FBI and Harvard professors ...Altimetry | SponsoredNVDA Crash UpdateAn overseas AI rival sent shockwaves through the U.S. tech market last week... Leaving millions of investor...Chaikin Analytics | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredNvidia > DeepSeekEveryone's getting it all wrong … Sure, DeepSeek's reveal caused AI stocks to tumble … But, in the long ...Weiss Ratings | Sponsored Is Starlink Set For The Largest IPO In History?He turned PayPal from a tiny, off-the-radar startup… to a massive $64 billion giant. Then, he did it again ...Paradigm Press | SponsoredBuy this AI Stock Before Elon’s AnnouncementWith Trump back in office, xAI is primed to become the leader in generative AI, leaving competitors in the dus...InvestorPlace | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding NovaBay Pharmaceuticals, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share NovaBay Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.